Cancer Nanotheranostics: Volume 2

Cancer Nanotheranostics, Volume 2 discusses the role of nanomaterials in cancer therapy, diagnosis, and therapy, including nano-based photothermal cancer therapy, nanoerythrosomes, and artificial intelligence. It is a comprehensive and unique examination of this important area of research.

Format: Paperback / softback
Length: 368 pages
Publication date: 06 October 2022
Publisher: Springer Nature Switzerland AG

Cancer Nanotheranostics,Volume 2, a comprehensive and insightful exploration into the realm of cancer nanotechnology, takes the discussion to new heights. This pivotal second volume delves deep into various aspects of this field, providing a detailed account of the significant work being conducted.

In the opening chapter, the authors shed light on the diverse roles played by nanomaterials in cancer therapy. They explore the utilization of lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies, among others. This comprehensive overview highlights the potential of these materials in combating cancer.

The second chapter delves into the realm of nano-based cancer diagnosis, emphasizing the use of nanotechnology to detect and diagnose cancer at an early stage. The authors discuss the development of novel imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), coupled with nanomaterials for enhanced detection and visualization of cancer cells. They also explore the use of nanomaterials in personalized medicine, where tailored treatment strategies can be developed based on individual patient characteristics.

Chapter three explores the application of nano-oncology for clinical applications, highlighting the potential benefits of nanotechnology in cancer treatment. The authors discuss the development of targeted drug delivery systems, nanomedicine, and nanotheranostics for cancer therapy. They also explore the use of nanotechnology in imaging-guided cancer surgery, where precise tumor targeting and removal can be achieved.

Chapter four delves into the realm of nano-immunotherapy, a promising approach for cancer treatment. The authors discuss the use of nanomaterials to enhance the immune system's response to cancer cells, including the development of immunotherapeutic agents and vaccines. They also explore the use of nanomaterials in combination with other therapies, such as chemotherapy and radiation therapy, to improve treatment outcomes.

Chapter five explores nano-based photothermal cancer therapy, a novel approach that utilizes light-activated nanomaterials to kill cancer cells. The authors discuss the development of photothermal agents, their mechanisms of action, and their potential applications in cancer treatment. They also explore the use of nanomaterials in combination with other therapies, such as chemotherapy and radiation therapy, to enhance treatment outcomes.

Chapter six explores nanoerythrosomes for cancer drug delivery, a promising approach that utilizes nanomaterials to enhance the delivery of drugs to cancer cells. The authors discuss the development of nanomaterials that can encapsulate drugs and release them in a controlled manner, targeting cancer cells while minimizing side effects. They also explore the use of nanomaterials in combination with other therapies, such as chemotherapy and radiation therapy, to improve treatment outcomes.

Chapter seven delves into regulatory perspectives of nanomaterials, emphasizing the need for robust regulations and guidelines to ensure the safe and effective use of nanomaterials in cancer nanotheranostics. The authors discuss the challenges associated with regulating nanomaterials and propose strategies for developing effective regulations that balance scientific innovation with public health and safety concerns.

Chapter eight explores the limitations of cancer nanotheranostics, highlighting the challenges and limitations that need to be addressed to further advance this field. The authors discuss the limitations of nanomaterials in terms of their stability, biocompatibility, and efficacy, as well as the challenges associated with developing effective delivery systems and targeting strategies. They also explore the need for interdisciplinary collaboration and collaboration between scientists, clinicians, and regulatory bodies to overcome these limitations.

Chapter nine explores the safety of nanobiomaterials for cancer nanotheranostics, emphasizing the need for rigorous safety testing and evaluation to ensure the safety of these materials. The authors discuss the potential risks and hazards associated with nanomaterials, as well as the strategies for assessing and mitigating these risks. They also explore the development of novel safety testing methodologies and the establishment of safety standards for nanomaterials in cancer nanotheranostics.

Chapter ten explores multifunctional nanomaterials for targeting cancer nanotheranostics, emphasizing the need for developing multifunctional nanomaterials that can target multiple cancer cells and pathways simultaneously. The authors discuss the development of nanomaterials that can deliver drugs, imaging agents, and therapeutic agents simultaneously, as well as the use of nanomaterials in combination with other therapies, such as chemotherapy and radiation therapy, to enhance treatment outcomes.

Chapter eleven explores the role of artificial intelligence in cancer nanotheranostics, emphasizing the potential of artificial intelligence to enhance the development and implementation of cancer nanotheranostics. The authors discuss the use of artificial intelligence in drug discovery, imaging analysis, and personalized medicine, as well as the use of artificial intelligence in developing effective treatment strategies and predicting treatment outcomes.

In conclusion, Cancer Nanotheranostics,Volume 2, is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research. The authors have assembled a team of experts from various fields to provide a comprehensive and up-to-date account of the latest developments in cancer nanotechnology. This book is a valuable resource for researchers, clinicians, and students interested in advancing the field of cancer nanotheranostics.

Weight: 587g
Dimension: 235 x 155 (mm)
ISBN-13: 9783030762650
Edition number: 1st ed. 2021